JBM (Healthcare) Limited

HK$1.60As of Sun 8 Nov 2026, 12:00 UTC
HKEX:2161Healthcare
Country Hong Kong
PE (Fwd) •••
TSR 6Y CAGR 0.13%
Div yield 10.65%
ROE 18.33%
Drug Manufacturers (Specialty & Generic)
Beta (5Y) 0.13
PE TTM 6.517
TSR TTM (41.69%)
Mkt cap HK$1.316B
ROIC 16.31%
SE Grade™
Value
Quality
Moat
Consensus
Reference
$1.71
6.45%
(60.15%)
Hold 2|11|6|5|8
3Q26
4Q26
1Q27
2Q27
Earnings per share$
0.02
0.02
0.02
0.02
20.19%
13.96%
0.58%
(2.18%)
Revenue$M
129.2
126.3
127.3
131.0
14.91%
9.53%
6.06%
4.69%
Peers (US$167.8M)
Cap (US$)
PE
Capital
TTM
5Y
10Y
Leveragex
1.697
(0.374)
(0.332)
EBIT/Intx
1.043
0.475
0.480
Own earn%
50.11
(62.61)
(46.14)
Sh yield%
36.97
30.00
28.83
Owners
Insiders/Inst%
7.73
38.91
Short interest%
2.21
SBC / revenue%
2.36
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
4
Op margin range%
12–21
$1 testx
0.0
Incr. ROIC%
1